The Latest Breaking News from Pfizer

Shares of Pfizer Inc. (NYSE:PFE) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on pharmaceuticals. This will enable Pfizer to offer its medication at significantly discounted prices compared to current rates.

The S&P 500 Index ($SPX ) (SPY ) today is down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.02%. December E-mini S&P futures (ESZ25 ) are down -0.05%, and December E-mini Nasdaq futures...

December S&P 500 E-Mini futures (ESZ25) are trending down -0.56% this morning as sentiment took a hit after the U.S. government shut down for the first time in seven years.

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

TrumpRx will slash US drug prices by up to 85% under a new deal with Pfizer, bringing costs in line with other nations and boosting US investment.

Weird how one happens before the other.

Senate Democrats voted down a Republican bill to keep funding the government, putting it on a near certain path to a shutdown. Key US politics stories from 30 September 2025

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.28%. December E-mini S&P futures (ESZ25 ) rose +0.39%, and December E-mini Nasdaq futures...

The Trump administration on Tuesday announced a deal granting Pfizer a three-year reprieve on planned tariffs as the pharmaceutical giant vowed to voluntarily lower the prices of unspecified drugs for US purchase.